of TNF inhibitor therapy on joint replacement rates in rheumatoid arthritis: A matched cohort analysis of BSRBR-RA registry
暂无分享,去创建一个
N. Arden | A. Judge | L. Dreyer | C. Edwards | K. Hyrich | D. Prieto-Alhambra | M. S. Ali | S. Hawley | C. Cooper
[1] A. Odgaard,et al. SAT0081 Changes in incidence of shoulder, elbow, wrist and finger replacement surgery among rheumatoid arthritis patients following the introduction of biological dmards: an interrupted time series analysis using danish health care registers , 2018, Saturday, 16 JUNE 2018.
[2] A. Silman,et al. The impact of rheumatoid arthritis on the risk of adverse events following joint replacement: a real-world cohort study , 2018, Clinical epidemiology.
[3] A. Silman,et al. Trends and determinants of length of stay and hospital reimbursement following knee and hip replacement: evidence from linked primary care and NHS hospital records from 1997 to 2014 , 2018, BMJ Open.
[4] A. Odgaard,et al. Incidence of hip and knee replacement in patients with rheumatoid arthritis following the introduction of biological DMARDs: an interrupted time-series analysis using nationwide Danish healthcare registers , 2017, Annals of the rheumatic diseases.
[5] A. Silman,et al. Association between NICE guidance on biologic therapies with rates of hip and knee replacement among rheumatoid arthritis patients in England and Wales: An interrupted time-series analysis. , 2017, Seminars in arthritis and rheumatism.
[6] J. O'dell,et al. Therapies for Active Rheumatoid Arthritis after Methotrexate Failure , 2017 .
[7] G. Collins,et al. Double-adjustment in propensity score matching analysis: choosing a threshold for considering residual imbalance , 2017, BMC Medical Research Methodology.
[8] Ashkan Ertefaie,et al. A tutorial on the use of instrumental variables in pharmacoepidemiology , 2017, Pharmacoepidemiology and drug safety.
[9] T. V. Vliet Vlieland,et al. Indication criteria for total hip or knee arthroplasty in osteoarthritis: a state-of-the-science overview , 2016, BMC Musculoskeletal Disorders.
[10] A. Mebazaa,et al. Propensity score estimators for the average treatment effect and the average treatment effect on the treated may yield very different estimates , 2016, Statistical methods in medical research.
[11] Y. Kawahito. [Guidelines for the management of rheumatoid arthritis]. , 2016, Nihon rinsho. Japanese journal of clinical medicine.
[12] S. Norton,et al. Association between rheumatoid arthritis disease activity, progression of functional limitation and long-term risk of orthopaedic surgery: combined analysis of two prospective cohorts supports EULAR treat to target DAS thresholds , 2016, Annals of the rheumatic diseases.
[13] L. Havelin,et al. Reduction in orthopaedic surgery in patients with rheumatoid arthritis: a Norwegian register-based study , 2016, Scandinavian journal of rheumatology.
[14] G. Jürgens,et al. Combination Therapy With and Without Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: A Meta‐Analysis of Randomized Trials , 2015, Arthritis care & research.
[15] O. FitzGerald,et al. Profound reduction in hospital admissions and musculoskeletal surgical procedures for rheumatoid arthritis with concurrent changes in clinical practice (1995-2010). , 2015, Rheumatology.
[16] L. Mandl,et al. US Trends in Rates of Arthroplasty for Inflammatory Arthritis Including Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritis , 2014, Arthritis & rheumatology.
[17] S. Norton,et al. Hand and Foot Surgery Rates in Rheumatoid Arthritis Have Declined From 1986 to 2011, but Large‐Joint Replacement Rates Remain Unchanged: Results From Two UK Inception Cohorts , 2014, Arthritis & rheumatology.
[18] L. Virta,et al. The decline in joint replacement surgery in rheumatoid arthritis is associated with a concomitant increase in the intensity of anti-rheumatic therapy , 2013, Acta orthopaedica.
[19] Y. Konttinen,et al. Do biologic drugs affect the need for and outcome of joint replacements in patients with rheumatoid arthritis? A register-based study. , 2013, Seminars in arthritis and rheumatism.
[20] Kristian Thorlund,et al. Why the findings of published multiple treatment comparison meta-analyses of biologic treatments for rheumatoid arthritis are different: an overview of recurrent methodological shortcomings , 2012, Annals of the rheumatic diseases.
[21] G. Hawker,et al. A systematic review and meta-analysis comparing complications following total joint arthroplasty for rheumatoid arthritis versus for osteoarthritis. , 2012, Arthritis and rheumatism.
[22] Georg Schett,et al. Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment , 2012, Nature Reviews Rheumatology.
[23] Jeffrey R Curtis,et al. A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial. , 2012, Arthritis and rheumatism.
[24] S. Gabriel,et al. Cardiomyopathy Caused by Longterm Treatment with Chloroquine: A Rare Disease or a Rare Diagnosis? , 2012, The Journal of Rheumatology.
[25] P. Ravaud,et al. Lack of head-to-head trials and fair control arms: randomized controlled trials of biologic treatment for rheumatoid arthritis. , 2012, Archives of internal medicine.
[26] D. Scott. Biologics‐Based Therapy for the Treatment of Rheumatoid Arthritis , 2012, Clinical pharmacology and therapeutics.
[27] J. Singh,et al. Use of biologics in rheumatoid arthritis: current and emerging paradigms of care. , 2011, Clinical therapeutics.
[28] G. Garellick,et al. Decrease in the incidence of total hip arthroplasties in patients with rheumatoid arthritis - results from a well defined population in south Sweden , 2011, Arthritis research & therapy.
[29] G. Jürgens,et al. Similar effects of disease-modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: meta-analysis of 70 randomized placebo-controlled or drug-controlled studies, including 112 comparisons. , 2010, Arthritis and rheumatism.
[30] E. Keystone,et al. Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: a meta-analysis of clinical and radiographic remission , 2010, Annals of the rheumatic diseases.
[31] Elizabeth A Stuart,et al. Matching methods for causal inference: A review and a look forward. , 2010, Statistical science : a review journal of the Institute of Mathematical Statistics.
[32] M. Ward,et al. Changes in the rates of joint surgery among patients with rheumatoid arthritis in California, 1983–2007 , 2009, Annals of the rheumatic diseases.
[33] P. Austin. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples , 2009, Statistics in medicine.
[34] Peter C. Austin,et al. Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research , 2009, Commun. Stat. Simul. Comput..
[35] Zoe Stableford,et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years). , 2006, Rheumatology.
[36] Peter C Austin,et al. The performance of different propensity-score methods for estimating relative risks. , 2008, Journal of clinical epidemiology.
[37] M Alan Brookhart,et al. Evaluating Short-Term Drug Effects Using a Physician-Specific Prescribing Preference as an Instrumental Variable , 2006, Epidemiology.
[38] N. Goodson,et al. British Society for Rheumatology and british health professionals in Rheumatology guideline for the management of rheumatoid arthritis (the first two years). , 2006, Rheumatology.
[39] R. Nelissen. The impact of total joint replacement in rheumatoid arthritis. , 2003, Best practice & research. Clinical rheumatology.
[40] R. Yood,et al. Guidelines for the management of rheumatoid arthritis: 2002 Update. , 2002, Arthritis and rheumatism.
[41] A Woolf,et al. The links between joint damage and disability in rheumatoid arthritis. , 2000, Rheumatology.
[42] C. Werning. [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.